VANCOUVER and MINNEAPOLIS - (NewMediaWire) - April 19, 2021 - Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ,TSX: NVCN) today announced that the journal EuroIntervention has published an article entitled, Coronary Sinus Reducer Implantation Results in Improved Oxygen Kinetics at Cardiopulmonary Exercise Test in Patients with...
Read MoreVANCOUVER and MINNEAPOLIS - (NewMediaWire) - April 16, 2021 - Neovasc Inc.("Neovasc" or the "Company") (NASDAQ,TSX: NVCN), today announced that the Tiara Transapical system (Tiara TA) will be unable to receive a European CE mark under the current Medical Device Directive regulations (MDD) ending on...
Read MoreVANCOUVER and MINNEAPOLIS – March 11, 2021 – Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), today reported financial results for the fourth quarter and fiscal year ended December 31, 2020. Fourth Quarter Highlights Generated revenue of $514,000 in the quarter and $1.96 million for the...
Read MoreVANCOUVER and MINNEAPOLIS - (NewMediaWire) - March 04, 2021 - Neovasc, Inc.(NASDAQ, TSX: NVCN) will report results for the fourth quarter and fiscal year ended December 31, 2020 after the market close on Thursday, March 11, 2021. Neovasc President and Chief Executive Officer Fred Colen...
Read MoreVANCOUVER and MINNEAPOLIS, March 3, 2021 – Neovasc Inc. (NASDAQ, TSX: NVCN), today announced that company management will be participating in the 2021 H.C. Wainwright Global Life Sciences Conference that is scheduled to take place March 9-10, 2021. A recorded presentation by Bill Little, Neovasc’s Chief...
Read MoreVANCOUVER and MINNEAPOLIS - (NewMediaWire) - March 02, 2021 - Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ,TSX: NVCN) today announced that the journal Clinical Cardiology has published an article entitled, Long-term outcomes of patients undergoing coronary sinus reducer implantation - A multicenter study. The article, authored...
Read MoreVancouver, British Columbia and Minneapolis, Minnesota – Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") has received written notification (the "Nasdaq Notice") from the Nasdaq Stock Market LLC ("Nasdaq") informing the Company that it has regained compliance with the minimum market value requirement set...
Read MoreVANCOUVER - (NewMediaWire) - February 17, 2021 - Neovasc Inc.(NASDAQ, TSX: NVCN), today announced that company management will be participating in the 10th Annual SVB Leerink Global Healthcare Conference that is scheduled to take place from February 24 to 26, 2021.Fred Colen, Neovasc's President and...
Read More